BOZZINI, Claudia
 Distribuzione geografica
Continente #
NA - Nord America 2.601
EU - Europa 2.446
AS - Asia 1.474
SA - Sud America 171
AF - Africa 20
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.719
Nazione #
US - Stati Uniti d'America 2.559
RU - Federazione Russa 948
SG - Singapore 609
GB - Regno Unito 572
CN - Cina 437
FI - Finlandia 159
SE - Svezia 154
DE - Germania 142
BR - Brasile 134
FR - Francia 126
VN - Vietnam 119
IT - Italia 116
HK - Hong Kong 112
IE - Irlanda 106
KR - Corea 57
NL - Olanda 41
UA - Ucraina 30
IN - India 28
CA - Canada 21
TR - Turchia 21
BD - Bangladesh 16
JP - Giappone 15
BE - Belgio 13
AR - Argentina 12
ID - Indonesia 12
MX - Messico 12
PL - Polonia 9
ES - Italia 8
IL - Israele 7
IQ - Iraq 6
AT - Austria 5
VE - Venezuela 5
ZA - Sudafrica 5
AL - Albania 4
AU - Australia 4
CL - Cile 4
EG - Egitto 4
PK - Pakistan 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
CO - Colombia 3
EC - Ecuador 3
JO - Giordania 3
NG - Nigeria 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
CY - Cipro 2
HN - Honduras 2
KG - Kirghizistan 2
KZ - Kazakistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
PT - Portogallo 2
SR - Suriname 2
TG - Togo 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MT - Malta 1
MW - Malawi 1
NP - Nepal 1
OM - Oman 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
Totale 6.719
Città #
Southend 477
Singapore 350
Jacksonville 340
Moscow 337
Chandler 287
San Jose 253
Ashburn 213
Woodbridge 181
Ann Arbor 161
Dallas 145
Houston 112
Hong Kong 111
Dublin 106
New York 71
Helsinki 66
Los Angeles 61
Verona 55
Munich 54
Ho Chi Minh City 46
Beijing 41
Lawrence 41
Princeton 41
Lancaster 39
The Dalles 38
Boardman 37
Nanjing 36
Wilmington 34
Hanoi 29
Tianjin 27
Jinan 25
Shenyang 20
Santa Clara 19
Zhengzhou 19
Buffalo 18
Turku 18
Milan 17
São Paulo 17
Falkenstein 16
Orem 15
Changsha 14
Hebei 14
Nanchang 14
Tokyo 14
Brussels 13
Seoul 13
Denver 12
Guangzhou 12
Jiaxing 12
Sindelfingen 12
Redondo Beach 11
Boston 10
Chennai 10
Norwalk 10
San Francisco 10
Seattle 10
Hangzhou 9
Columbus 8
Fuzhou 8
Montreal 8
Toronto 8
Atlanta 7
Rio de Janeiro 7
Stockholm 7
Taiyuan 7
Warsaw 7
Lanzhou 6
Manchester 6
Mestre 6
Amsterdam 5
Ankara 5
Dongguan 5
Fortaleza 5
Haikou 5
London 5
Mexico City 5
Ningbo 5
Poplar 5
Barnet 4
Cagliari 4
Council Bluffs 4
Haiphong 4
Kochi 4
Naples 4
Perugia 4
San Mateo 4
Tirana 4
Vienna 4
Washington 4
Abuja 3
Baghdad 3
Baku 3
Brasília 3
Brooklyn 3
Campinas 3
Caracas 3
Chicago 3
Clearwater 3
Curitiba 3
Da Nang 3
Dhaka 3
Totale 4.383
Nome #
Novel serum paraoxonase activity assays are associated with coronary artery disease 217
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 199
Biochemical and genetic markers of iron status and the risk of coronary disease 195
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 188
Clinical and pathological findings in hemochromatosis type 3 due to a novel mutation in transferin receptor 2 gene 184
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 183
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 180
Clinical heterogeneity of acquired hemophilia A: a description of 4 cases. 176
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 176
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 173
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 170
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 168
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 168
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 167
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 166
A new mutation in transferrin receptor 2 gene in hemochromatosis type 3 166
Determinants of serum ferritin in the metabolic syndrome. 165
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 165
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 164
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 164
Prevalence of body iron excess in the metabolic syndrome. 160
Clinical,biochemical and molecular findings in a series of families with hereditary hyperferritinemia cataract syndrome 159
BIOCHEMICAL AND GENETIC MARKERS OF IRON STATUS AND RISK OF CORONARY ARTERY DISEASE: AN ANGIOGRAPHIC-BASED STUDY. 157
A new mutation in the trnsferrin receptor 2 gene in hemochromatosis type 3 154
Two new highly polymorphic markers in the 3’UTR region of the PLA2G7 gene 151
CLINICAL AND HISTOPATHOLOGICAL FINDINGS IN A FAMILY WITH HEMOCROMATOSIS TYPE 3, CARRING A NEW MUTATION IN TRANSFERRIN RECEPTOR 2 GENE 150
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 150
Met-Leu and Gln-Arg PON 1 polymorphisms and mortality after coronary artery by-pass grafing surgery. 144
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 144
Blunted hepcidin response to oral iron challenge in BFE-related hemochromatosis 138
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 134
Prevalence of hereditary hyperferritinemia-catarat siyndrome in blood donors and in patients with cataract 131
Red Blood Cell Morphologic Abnormalities in Patients Hospitalized for COVID-19 129
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 126
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease 126
Influence of the polymorphism in the factor VII gene promoter on Factor VII circulating levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 125
Molecular pathology of hereditary hemochromatosis 124
Increase arachidonic/linoleic acid ratio and a polygenic model of desaturases polymorphism are associated with increase risk of coronary artery disease 116
Anemia in patients receiving anticancer treatments: focus on novel therapeutic approaches 113
A case series of patients with β-thalassemia trait and iron overload: from multifactorial hepcidin suppression to treatment with mini-phlebotomies 103
Polymorphism in the factor VII gene promoter (-323°1°2 and -402 GA) and the risk of myocardial infarction in patients with advance coronary atherosclerosis 103
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 99
Serum Erythroferrone in a Large General Population: Towards a Better Understanding of Connections Between Erythropoiesis and Iron Homeostasis 92
Prevalence of hereditary hyperferritinemia-cataract syndrome in blood donors and in patients with cataract. 92
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 82
Totale 6.736
Categoria #
all - tutte 20.055
article - articoli 9.603
book - libri 0
conference - conferenze 10.089
curatela - curatele 0
other - altro 363
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 2 37 1
2021/2022296 26 70 3 33 18 9 4 18 6 13 28 68
2022/2023803 47 84 74 143 97 179 5 36 95 10 15 18
2023/2024411 8 29 27 44 42 77 9 34 5 18 56 62
2024/2025922 49 74 71 156 32 40 28 17 80 45 93 237
2025/20262.611 199 152 148 484 827 180 177 108 207 129 0 0
Totale 6.736